DRIVe EZ-BAA
SOL #: BAA-18-100-SOL-00018Combined Synopsis/Solicitation
Overview
Buyer
Buyer not available
Place of Performance
WASHINGTON, DC
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
PSC
Research And Development (A)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Jun 18, 2018
2
Last Updated
Aug 23, 2018
3
Submission Deadline
Jun 1, 2019, 4:59 AM
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
8/23/2018 - Amendment 0002 posted. This amendment includes revisions to Section II(F) and Section IV.
7/30/2018 - Amendment 0001 posted. This amendment includes revisions to Section III(A), Section III(C)(1), and Section III(C)(2).
7/27/2018 - Questions and Answers #2 posted.
6/19/2018 - EZ BAA Pre-Proposal Conference Details posted.
6/18/2018 - Questions and Answers #1 posted.
7/30/2018 - Amendment 0001 posted. This amendment includes revisions to Section III(A), Section III(C)(1), and Section III(C)(2).
7/27/2018 - Questions and Answers #2 posted.
6/19/2018 - EZ BAA Pre-Proposal Conference Details posted.
6/18/2018 - Questions and Answers #1 posted.
People
Points of Contact
Troy FrancisContracting OfficerPRIMARY
Files
Versions
Version 5Viewing
Combined Synopsis/Solicitation
Posted: Aug 23, 2018
Version 4
Combined Synopsis/Solicitation
Posted: Jul 30, 2018
Version 3
Combined Synopsis/Solicitation
Posted: Jul 27, 2018
Version 2
Combined Synopsis/Solicitation
Posted: Jun 19, 2018
Version 1
Combined Synopsis/Solicitation
Posted: Jun 18, 2018